It looks like you're using an Ad Blocker.
Please white-list or disable AboveTopSecret.com in your ad-blocking tool.
Thank you.
Some features of ATS will be disabled while you continue to use an ad-blocker.
Well, this is nice. According to the following report, BioNTech (the German agency of Pfizer) says it cannot guarantee the efficacy and safety of its experimental mRNA treatment that is intended to mitigate the consequences of contamination with the Coronavirus. To make matters worse, it also says it is unable to definitively prevent financial fraud within its own corporate structure, writes Baron Bodissey.
In assessing the safety of its own vaccine, BioNTech contradicts the statements of politicians, many doctors and the media on almost every point. The statement further reads: “We may not be able to demonstrate sufficient efficacy or safety of our Corona vaccine and/or variant-specific formulations to warrant continued regulatory approval in the United States, United Kingdom, European Union or other countries where it has been approved for emergency use or where conditional market approval has been granted.” The classification of possible side effects is contrary to the insurance of the Ministry of Health, the doctors or the committees: “Severe side effects can occur during our clinical trials or even after receiving the regulatory approval that could affect the clinical trials, the regulatory delay or terminate approval or market acceptance of any of our product candidates.” BioNTech clearly admits that vaccine protection is short-lived and that there is no evidence from clinical studies. The success of the vaccine also depends on “whether previously unknown side effects or an increased incidence or severity of known side effects compared to those observed during the clinical trial with our vaccine”. BioNTech also cannot “guarantee that newly discovered or developed security issues will not arise.” Contrary to those who argue that there are no long-term effects of vaccination because side effects always occur immediately, BioNTech states in the report: “When a vaccine is used by a large patient population, serious side effects can occur from time to time, which are not in the mainstream. clinical trials of the product or which initially appeared to be unrelated to the vaccine itself and only recognized by subsequent information.” This could lead to the vaccine having to be withdrawn from the market and the threat of "significant liability" claims. According to BioNTech, future revenues also depend on how the virus develops and whether a vaccine is actually still needed if the virus is simply endemic.
It's all about the money.
- This post examines a growing COVID-19 vaccine gap in Red and Blue America, with the share of the population that have been fully vaccinated in counties that voted for President Biden in 2020 increasing more rapidly than the share in counties that voted for President Trump.
originally posted by: Sander1976
So now go read all the attached docs and come back later
a reply to: andy06shake
This could lead to the vaccine having to be withdrawn from the market and the threat of "significant liability" claims. According to BioNTech, future revenues also depend on how the virus develops and whether a vaccine is actually still needed if the virus is simply endemic.
originally posted by: chr0naut
a reply to: Sander1976
11.2 billion doses administered worldwide, some of which were more than 1 year ago, and people are still calling it "experimental".
Luddites.
originally posted by: andy06shake
a reply to: v1rtu0s0
Hi v1rtu0s0.
Care to explain why we here in the UK are not all dead with AIDS yet?
originally posted by: andy06shake
a reply to: Sander1976
It's all about the money.
Very true but also the case long before COVID 19 or mRNA vaccines materialised.
originally posted by: andy06shake
a reply to: v1rtu0s0
Hi v1rtu0s0.
Care to explain why we here in the UK are not all dead with AIDS yet?
originally posted by: andy06shake
a reply to: v1rtu0s0
No its not, not in the slightest.